InsiderClue
Insiders · Profile

SANDELL SCOTT D

10% owner at Korro Bio · 10% owner at SpyGlass Pharma · 10% owner at MBX Biosciences · and 18 more. Filing since 10 Apr 2013. CIK 0001237289

KRRO Korro Bio, Inc. 10% owner · 2 trades SGP SpyGlass Pharma, Inc. 10% owner · 1 trade MBX MBX Biosciences, Inc. 10% owner · 1 trade NET Cloudflare, Inc. Director · 22 trades SVRA Savara Inc 10% owner · 1 trade CBIO CRESCENT BIOPHARMA, INC. 10% owner · 10 trades HOOD Robinhood Markets Director · 3 trades TRVI Trevi Therapeutics, Inc. 10% owner · 4 trades ARDX ARDELYX, INC. 10% owner · 17 trades GLUE Monte Rosa Therapeutics, Inc. 10% owner · 1 trade MRKR Marker Therapeutics, Inc. 10% owner · 1 trade NKTX Nkarta, Inc. 10% owner · 1 trade MIRM Mirum Pharmaceuticals, Inc. 10% owner · 1 trade BE Bloom Energy Corp Director · 1 trade ORKA Oruka Therapeutics, Inc. 10% owner · 1 trade APPN APPIAN CORP 10% owner · 2 trades RYTM RHYTHM PHARMACEUTICALS, INC. 10% owner · 1 trade SUPN SUPERNUS PHARMACEUTICALS, INC. 10% owner · 4 trades WDAY Workday, Inc. Director · 3 trades GYRE GYRE THERAPEUTICS, INC. 10% owner · 2 trades GRPN Groupon, Inc. 10% owner · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
KRRO Korro Bio, Inc.
10 Mar 2026
10% owner
Bought
207,100
$2.30M
19.0%
SGP SpyGlass Pharma, Inc.
9 Feb 2026
10% owner
Bought
937,500
$15.00M
18.4%
MBX MBX Biosciences, Inc.
16 Sep 2024
10% owner
Bought
500,000
$8.00M
16.1%
KRRO Korro Bio, Inc.
22 Apr 2024
10% owner
Bought
17,857
$999.99K
1.7%
NET Cloudflare, Inc.
20 Nov 2023
Director
Sold on a plan
211,534
$15.48M
100%
NET Cloudflare, Inc.
8 Aug 2023
Director
Sold at will
20,307
$1.33M
100%
SVRA Savara Inc
17 Jul 2023
10% owner
Bought
333,333
$1,000.00K
1.4%
CBIO CRESCENT BIOPHARMA, INC.
26 Jan 2023
10% owner
Sold, plan not stated
3,000,000
$9.36M
57.3%
CBIO CRESCENT BIOPHARMA, INC.
25 Jan 2023
10% owner
Sold, plan not stated
652,016
$2.13M
15.4%
CBIO CRESCENT BIOPHARMA, INC.
5 Jan 2023
10% owner
Sold, plan not stated
71,362
$196.86K
1.8%
CBIO CRESCENT BIOPHARMA, INC.
4 Jan 2023
10% owner
Sold, plan not stated
101,984
$296.74K
2.5%
CBIO CRESCENT BIOPHARMA, INC.
3 Jan 2023
10% owner
Sold, plan not stated
174,814
$522.71K
4.2%
CBIO CRESCENT BIOPHARMA, INC.
30 Dec 2022
10% owner
Sold, plan not stated
121,335
$366.43K
2.9%
NET Cloudflare, Inc.
14 Jun 2022
Director
Sold, plan not stated
2,441
$99.87K
41.4%
HOOD Robinhood Markets
12 May 2022
Director
Sold, plan not stated
8,792
$73.94K
100%
HOOD Robinhood Markets
3 May 2022
Director
Sold, plan not stated
1,952
$19.64K
100%
TRVI Trevi Therapeutics, Inc.
11 Apr 2022
10% owner
Bought
3,580,526
$6.80M
52.3%
NET Cloudflare, Inc.
14 Feb 2022
Director
Sold, plan not stated
6,622
$701.17K
73.1%
HOOD Robinhood Markets
31 Jan 2022
Director
Sold, plan not stated
2,082
$29.60K
100%
ARDX ARDELYX, INC.
15 Dec 2021
10% owner
Sold, plan not stated
1,211,352
$1.38M
34.9%
ARDX ARDELYX, INC.
14 Dec 2021
10% owner
Sold, plan not stated
1,000,735
$1.25M
30.5%
ARDX ARDELYX, INC.
9 Dec 2021
10% owner
Sold, plan not stated
669,483
$1.01M
21.3%
TRVI Trevi Therapeutics, Inc.
18 Oct 2021
10% owner
Bought
1,851,852
no price
31.2%
GLUE Monte Rosa Therapeutics, Inc.
28 Jun 2021
10% owner
Bought
1,050,000
$19.95M
15.8%
MRKR Marker Therapeutics, Inc.
16 Mar 2021
10% owner
Bought
5,714,285
$10.00M
114%
NET Cloudflare, Inc.
20 Nov 2020
Director
Sold, plan not stated
69,661
$4.69M
100%
NET Cloudflare, Inc.
19 Nov 2020
Director
Sold, plan not stated
267,743
$17.63M
79.4%
NET Cloudflare, Inc.
18 Nov 2020
Director
Sold, plan not stated
51,428
$3.37M
13.2%
NET Cloudflare, Inc.
17 Nov 2020
Director
Sold, plan not stated
312,171
$20.48M
44.5%
NET Cloudflare, Inc.
16 Nov 2020
Director
Sold, plan not stated
86,980
$5.59M
11.0%
NET Cloudflare, Inc.
13 Nov 2020
Director
Sold, plan not stated
73,796
$4.72M
8.6%
NET Cloudflare, Inc.
12 Nov 2020
Director
Sold, plan not stated
11,884
$772.71K
1.4%
NET Cloudflare, Inc.
20 Aug 2020
Director
Sold, plan not stated
438,500
$17.54M
100%
NET Cloudflare, Inc.
19 Aug 2020
Director
Sold, plan not stated
800
$32.02K
0.2%
NET Cloudflare, Inc.
18 Aug 2020
Director
Sold, plan not stated
100,700
$4.03M
18.6%
NET Cloudflare, Inc.
17 Aug 2020
Director
Sold, plan not stated
88,600
$3.49M
14.1%
NET Cloudflare, Inc.
14 Aug 2020
Director
Sold, plan not stated
61,400
$2.38M
8.9%
NET Cloudflare, Inc.
13 Aug 2020
Director
Sold, plan not stated
37,444
$1.46M
5.1%
NET Cloudflare, Inc.
12 Aug 2020
Director
Sold, plan not stated
250,000
$9.83M
25.6%
NET Cloudflare, Inc.
11 Aug 2020
Director
Sold, plan not stated
328,402
$12.33M
25.1%
NET Cloudflare, Inc.
10 Aug 2020
Director
Sold, plan not stated
92,163
$3.45M
6.6%
NKTX Nkarta, Inc.
14 Jul 2020
10% owner
Bought
666,666
$12.00M
29.8%
ARDX ARDELYX, INC.
15 Jun 2020
10% owner
Sold, plan not stated
43
$273.91
100%
ARDX ARDELYX, INC.
12 Jun 2020
10% owner
Sold, plan not stated
44,992
$288.68K
99.9%
ARDX ARDELYX, INC.
11 Jun 2020
10% owner
Sold, plan not stated
44,991
$284.46K
50.0%
NET Cloudflare, Inc.
21 May 2020
Director
Sold, plan not stated
174,777
$4.88M
100%
NET Cloudflare, Inc.
20 May 2020
Director
Sold, plan not stated
174,777
$4.76M
50.0%
TRVI Trevi Therapeutics, Inc.
3 Apr 2020
10% owner
Sold, plan not stated
564
$1.50K
0.0%
MIRM Mirum Pharmaceuticals, Inc.
22 Jul 2019
10% owner
Bought
450,000
$6.75M
12.0%
TRVI Trevi Therapeutics, Inc.
9 May 2019
10% owner
Bought
2,500,000
$25.00M
129%
ARDX ARDELYX, INC.
12 Nov 2018
10% owner
Sold, plan not stated
592
$1.77K
100%
BE Bloom Energy Corp
27 Jul 2018
Director
Bought
1,333,333
$20.00M
opened
CBIO CRESCENT BIOPHARMA, INC.
10 May 2018
10% owner
Sold, plan not stated
9,539
$169.89K
0.2%
ORKA Oruka Therapeutics, Inc.
26 Feb 2018
10% owner
Sold, plan not stated
1,460,209
$731.27K
100%
APPN APPIAN CORP
27 Nov 2017
10% owner
Sold, plan not stated
569,620
$11.10M
100%
APPN APPIAN CORP
20 Nov 2017
10% owner
Sold, plan not stated
2,820,516
$54.97M
100%
RYTM RHYTHM PHARMACEUTICALS, INC.
10 Oct 2017
10% owner
Bought
550,000
$9.35M
12.6%
ARDX ARDELYX, INC.
18 Jul 2016
10% owner
Bought
763,651
$6.67M
40.2%
ARDX ARDELYX, INC.
18 Jul 2016
10% owner
Bought
763,650
$6.67M
40.2%
ARDX ARDELYX, INC.
18 Jul 2016
10% owner
Bought
763,650
$6.67M
9.6%
ARDX ARDELYX, INC.
13 Jan 2016
10% owner
Bought
500,000
$5.00M
35.7%
ARDX ARDELYX, INC.
13 Jan 2016
10% owner
Bought
500,000
$5.00M
6.7%
ARDX ARDELYX, INC.
13 Jan 2016
10% owner
Bought
500,000
$5.00M
35.7%
CBIO CRESCENT BIOPHARMA, INC.
16 Nov 2015
10% owner
Sold, plan not stated
452
$3.12K
0.0%
SUPN SUPERNUS PHARMACEUTICALS, INC.
17 Jun 2015
10% owner
Sold, plan not stated
111,881
$1.83M
100%
SUPN SUPERNUS PHARMACEUTICALS, INC.
17 Jun 2015
10% owner
Sold, plan not stated
24,716
$420.82K
100%
SUPN SUPERNUS PHARMACEUTICALS, INC.
16 Jun 2015
10% owner
Sold, plan not stated
55,105
$928.67K
33.0%
SUPN SUPERNUS PHARMACEUTICALS, INC.
16 Jun 2015
10% owner
Sold, plan not stated
40,332
$685.90K
62.0%
ARDX ARDELYX, INC.
5 Jun 2015
10% owner
Bought
1,869,159
$20.00M
33.3%
ARDX ARDELYX, INC.
5 Jun 2015
10% owner
Bought
1,401,869
$15.00M
opened
ARDX ARDELYX, INC.
5 Jun 2015
10% owner
Bought
1,401,869
$15.00M
opened
ARDX ARDELYX, INC.
26 Dec 2014
10% owner
Sold, plan not stated
1,972
$41.96K
100%
WDAY Workday, Inc.
28 Feb 2014
Director
Sold, plan not stated
4,930
$535.46K
100%
CBIO CRESCENT BIOPHARMA, INC.
15 Jan 2014
10% owner
Bought
512,500
$4.10M
14.3%
CBIO CRESCENT BIOPHARMA, INC.
15 Jan 2014
10% owner
Bought
487,500
$3.90M
12.2%
WDAY Workday, Inc.
9 Dec 2013
Director
Sold, plan not stated
4,924
$392.32K
50.0%
GYRE GYRE THERAPEUTICS, INC.
5 Dec 2013
10% owner
Sold, plan not stated
1,000
$5.13K
100%
GYRE GYRE THERAPEUTICS, INC.
21 Nov 2013
10% owner
Sold, plan not stated
5,333
$27.53K
84.2%
GRPN Groupon, Inc.
15 Aug 2013
10% owner
Sold, plan not stated
27,595
$269.63K
100%
GRPN Groupon, Inc.
15 Aug 2013
10% owner
Sold, plan not stated
7,692
$75.77K
100%
WDAY Workday, Inc.
10 Apr 2013
Director
Sold, plan not stated
10,396
$605.74K
100%
81 decisions on file.